NCT07745244Recruiting
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System Across Varying Blood Glucose Ranges
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
The study is to evaluate the accuracy and safety of a real-time CGM system among adult patients with type 1 diabetes with respect to reference venous plasma sample measurements.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 29 Jul 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 1 Jun 2027
- Lead sponsor
- SiBionics, Co, Ltd
- Diseases
- Type 1 diabetes
- NCT number
- NCT07745244
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 1 Jun 2026 to the primary completion date, 1 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Heart failure or hemiplegic sequelae due to prior cerebrovascular disease
Other illness
- Severe skin conditions at the sensor wear site
- Extensive systemic skin disorders
- Coagulation disorders confirmed by the investigator
- Allergy to medical adhesives or alcohol
- Conditions impairing comprehension of informed consent or study procedures
- Other exclusionary conditions per investigator's discretion
Age
- Pregnancy (defined as positive urine test in women ≤55 years), lactation, or plans for pregnancy within ≤30 days
Other
- Severe hypoglycemia within the past 6 month
- Anemia or abnormal hematocrit
- Blood donation within the past 6 months
- Current or recent (≤1 month) participation in other clinical trials
- Planned MRI/CT scans during sensor wear
Who the study is looking for
- Age ≥ 18 years
- Diagonsed with T1D
- Venous blood sampling access can be established in the forearm
- Capable of independently reading instructions and complying with the clinical trial requirements
- Willing to sign the Informed Consent Form (ICF)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zibo Central hospital Coordinator of this site? Confirm its status | Zibo | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.